Thank you.
Now we'll go to the witnesses. Pursuant to Standing Order 81(4), main estimates 2009-10, we will now go straight to the witnesses.
From the Hazardous Materials Information Review Commission, we have the president and chief executive officer, Sharon Watts. From Assisted Human Reproduction Canada, we have Elinor Wilson, the president and chief executive officer, and Margaret Strysio, the executive director of planning, communications, and outreach. Welcome.
From the Patented Medicine Prices Review Board, we have Brian Benoit, the chairperson, and Barbara Ouellet, the executive director. From the Canadian Institutes of Health Research, we have Karl Tibelius, the director of the targeted initiatives research portfolio, and James Roberge, the chief financial officer and the vice-president of resource planning and management.
We will start with our first witness, Sharon Watts, from the Hazardous Materials Information Review Commission. You have a ten-minute presentation. Once we hear all of the presentations, we'll go into Q and A.